Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping

Author： Innocenti Federico Ratain Mark J

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.8, 2006-12, pp. : 1211-1221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Utility of Thiopurine S -Methyltransferase Genotyping

By Corominas H.

American Journal of PharmacoGenomics, Vol. 4, Iss. 1, 2004-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

The Potential Utility of HPV Genotyping in Screening and Clinical Management

By Castle Philip E.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 1, 2008-01 ,pp. : 83-95

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacogenetics of irinotecan toxicity

By Marsh Sharon McLeod Howard L

Pharmacogenomics, Vol. 5, Iss. 7, 2004-10 ,pp. : 835-843

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications

By Mayo Clara Bertran-Alamillo Jordi Molina-Vila Miguel Ángel Giménez-Capitán Ana Costa Carlota Rosell Rafael

Pharmacogenomics, Vol. 13, Iss. 7, 2012-05 ,pp. : 789-802

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 209-217

Bentham Science Publishers

Access to resources Recommend Favorite